XML 51 R40.htm IDEA: XBRL DOCUMENT
v3.25.3

SEGMENT INFORMATION (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Segment Reporting [Abstract] |
Schedule of Reconciliation of Assets by Reportable Segment to Consolidated Assets | The following tables present amounts for each of our reportable segments and the reconciling items necessary to agree to amounts reported in the accompanying Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Operations, as applicable.
|  | September 30, 2025 |  | December 31, 2024
Assets: |  |  |  |
Hospital Operations |  | $ | 16,530 |  |  | $ | 16,722 |
Ambulatory Care |  | 12,888 |  |  | 12,214 |
Total |  | $ | 29,418 |  |  | $ | 28,936 |
Schedule of Reconciliation of Other Significant Reconciling Items From Segments to Consolidated |
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
Capital expenditures: |  |  |  |  |  |  |  |
Hospital Operations |  | $ | 242 |  |  | $ | 188 |  |  | $ | 556 |  |  | $ | 536 |
Ambulatory Care |  | 38 |  |  | 28 |  |  | 90 |  |  | 65 |
Total |  | $ | 280 |  |  | $ | 216 |  |  | $ | 646 |  |  | $ | 601 |
Depreciation and amortization: |  |  |  |  |  |  |  |
Hospital Operations |  | $ | 182 |  |  | $ | 171 |  |  | $ | 522 |  |  | $ | 523 |
Ambulatory Care |  | 36 |  |  | 38 |  |  | 110 |  |  | 102 |
Total |  | $ | 218 |  |  | $ | 209 |  |  | $ | 632 |  |  | $ | 625 |
| Three Months Ended September 30, 2025 |  | Nine Months Ended September 30, 2025
| Hospital Operations |  | Ambulatory Care |  | Total |  | Hospital Operations |  | Ambulatory Care |  | Total
Net operating revenues | $ | 4,014 |  |  | $ | 1,275 |  |  | $ | 5,289 |  |  | $ | 12,044 |  |  | $ | 3,739 |  |  | $ | 15,783 |
Equity in earnings of unconsolidated affiliates | 1 |  |  | 63 |  |  | 64 |  |  | 5 |  |  | 176 |  |  | 181 |
Less: |  |  |  |  |  |  |  |  |  |  |
Salaries, wages and benefits | 1,888 |  |  | 316 |  |  | 2,204 |  |  | 5,558 |  |  | 925 |  |  | 6,483 |
Supplies | 594 |  |  | 337 |  |  | 931 |  |  | 1,783 |  |  | 987 |  |  | 2,770 |
Other operating expenses, net | 926 |  |  | 193 |  |  | 1,119 |  |  | 2,771 |  |  | 557 |  |  | 3,328 |
Adjusted EBITDA | $ | 607 |  |  | $ | 492 |  |  | 1,099 |  |  | $ | 1,937 |  |  | $ | 1,446 |  |  | 3,383 |
Reconciliation of Adjusted EBITDA: |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization |  |  |  |  | (218) |  |  |  |  |  |  | (632) |
Impairment and restructuring charges, and acquisition-related costs |  |  |  |  | (23) |  |  |  |  |  |  | (66) |
Litigation and investigation benefit (costs) |  |  |  |  | 11 |  |  |  |  |  |  | (34) |
Interest expense |  |  |  |  | (206) |  |  |  |  |  |  | (616) |
Other non-operating income, net |  |  |  |  | 29 |  |  |  |  |  |  | 80 |
Net gains on sales, consolidation and deconsolidation of facilities |  |  |  |  | 20 |  |  |  |  |  |  | 4 |
Income before income taxes |  |  |  |  | $ | 712 |  |  |  |  |  |  | $ | 2,119 |
| Three Months Ended September 30, 2024 |  | Nine Months Ended September 30, 2024
| Hospital Operations |  | Ambulatory Care |  | Total |  | Hospital Operations |  | Ambulatory Care |  | Total
Net operating revenues | $ | 3,987 |  |  | $ | 1,139 |  |  | $ | 5,126 |  |  | $ | 12,327 |  |  | $ | 3,275 |  |  | $ | 15,602 |
Equity in earnings of unconsolidated affiliates | 1 |  |  | 61 |  |  | 62 |  |  | 7 |  |  | 175 |  |  | 182 |
Less: |  |  |  |  |  |  |  |  |  |  |
Salaries, wages and benefits | 1,908 |  |  | 310 |  |  | 2,218 |  |  | 5,876 |  |  | 831 |  |  | 6,707 |
Supplies | 597 |  |  | 284 |  |  | 881 |  |  | 1,860 |  |  | 857 |  |  | 2,717 |
Other operating expenses, net | 944 |  |  | 167 |  |  | 1,111 |  |  | 2,931 |  |  | 482 |  |  | 3,413 |
Adjusted EBITDA | $ | 539 |  |  | $ | 439 |  |  | 978 |  |  | $ | 1,667 |  |  | $ | 1,280 |  |  | 2,947 |
Reconciliation of Adjusted EBITDA: |  |  |  |  |  |  |  |  |  |  |
Depreciation and amortization |  |  |  |  | (209) |  |  |  |  |  |  | (625) |
Impairment and restructuring charges, and acquisition-related costs |  |  |  |  | (19) |  |  |  |  |  |  | (75) |
Litigation and investigation costs |  |  |  |  | (9) |  |  |  |  |  |  | (18) |
Interest expense |  |  |  |  | (202) |  |  |  |  |  |  | (623) |
Loss from early extinguishment of debt |  |  |  |  | — |  |  |  |  |  |  | (8) |
Other non-operating income, net |  |  |  |  | 35 |  |  |  |  |  |  | 89 |
Net gains on sales, consolidation and deconsolidation of facilities |  |  |  |  | 348 |  |  |  |  |  |  | 2,906 |
Income before income taxes |  |  |  |  | $ | 922 |  |  |  |  |  |  | $ | 4,593 |

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of reconciliation of other items from reportable segments to their consolidated amount. Excludes reconciliation of revenue, profit (loss), and assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration